ClinicalTrials.Veeva

Menu

Effects of AN69 ST Hemofilter on Coagulation During Continuous Renal Replacement Therapy in Critically Ill

S

Southeast University

Status

Unknown

Conditions

Critically Ill
Acute Kidney Injury
Septic Shock

Treatments

Device: AN 69 hemofilter
Device: AN 69 ST hemofilter

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Compared with AN69 hemofilter, AN69 ST hemofilter may prolong the time of hemofilter and decrease the quantity of heparin during continuous renal replacement therapy in critically ill.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age> 18 years old
  • admitted to ICU and need CRRT
  • anticipated survival time >72h

Exclusion criteria

  • allergy to hemofilter or heparin
  • heparin associated thrombocytopenia
  • pregnancy or lactation
  • using other anticoagulate drugs

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

AN 69 ST hemofilter
Experimental group
Description:
Use AN 69 ST hemofilter during CRRT
Treatment:
Device: AN 69 ST hemofilter
AN 69 hemofilter
Active Comparator group
Description:
Use AN 69 hemofilter during CRRT
Treatment:
Device: AN 69 hemofilter

Trial contacts and locations

1

Loading...

Central trial contact

Qiu Xiaohua

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems